Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

SENS vs VTAK: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

SENS Wins Head-to-Head Institutional Verdict (5–0 across 6 Pillars · 5–5 Matrix Metrics)

SENS Overall Winner 6-Pillar Tally: SENS 5 – 0 VTAK (1 Tie) Matrix Metrics: SENS 5 – 5 VTAK

As of Nov 16, 2026, Senseonics Holdings, Inc. (SENS) is the stronger overall head-to-head candidate over Catheter Precision, Inc. (VTAK) in the Tradestie Institutional Equity Comparison Engine, winning 5–5 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). SENS carries a Unified Composite Score of 38.9/100 (SELL) at $10.90 (21.0x Forward P/E, -201.0% operating margin), whereas VTAK carries 58.1/100 (HOLD) at $0.15 (N/M Forward P/E, -388.1% operating margin).

  • Composite vs. Pillar Nuance: While VTAK currently prints a higher short-term Unified Composite Score (58.1/100 HOLD vs. SENS 38.9/100 SELL), SENS captures the overall institutional head-to-head verdict (5–5 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (-201.0% vs. -388.1% operating margin) and revenue trajectory (+141.6% vs. +380.7% YoY).
  • Technical & Structure Timing Caution: SENS trades in a Markup technical trend (CONSOLIDATION options phase, RSI 64.1); meanwhile VTAK is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 33.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About SENS vs VTAK
SENS NYSE American Head-to-Head Winner
Senseonics Holdings, Inc.
Industrial Instruments For Measurement, Display, And Control
$10.90
+3.02% 1D
Market Cap $579.6M
TTM Revenue $60M
Forward P/E 21.0x
Beta / 30D Vol 1.98β · 101% Vol
Unified Composite Score
38.9 / 100 SELL
Tech 15.0 Fund 44.0 Flow 57.0 Mom 70.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (0.5% over 20 days), RSI 64
RSI-14: 64.1 · SMA20: $9.04 · SMA50: $9.20
VTAK NYSE American
Catheter Precision, Inc.
Surgical & Medical Instruments & Apparatus
$0.15
-0.66% 1D
Market Cap $548,639
TTM Revenue $1.9M
Forward P/E N/M
Beta / 30D Vol 0.19β · 76% Vol
Unified Composite Score
58.1 / 100 HOLD
Tech 72.0 Fund 70.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -53.4%), weak momentum, RSI 33
RSI-14: 33.2 · SMA20: $0.16 · SMA50: $0.21

6-Pillar Scorecard Institutional Category Breakdown (SENS 5 – 0 VTAK)

Columns: Metric · SENS · VTAK
1. Valuation Multiples SENS
Forward P/E 21.0x N/M
Trailing P/E 21.0x N/M
PEG Ratio N/M N/M
EV / Revenue 9.9x 0.3x
2. Growth & Scale SENS
Revenue Growth (YoY) +141.6% +380.7%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) $60M $1.9M
Market Cap $579.6M $548,639
3. Profitability & Quality SENS
Gross Margin 58.7% 47.7%
Operating Margin -201.0% -388.1%
Net Profit Margin -204.2% 0.0%
Return on Equity (ROE) -157.3% -111.3%
4. Balance Sheet & Cash Flow SENS
Cash Generation (TTM) -$114M -$10M EBITDA
Cash Flow Margin N/A N/A
Net Cash / Leverage $13M Net Debt (0.79x D/E) $4.87 Book/Sh · -111.3% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning SENS
Options Structure Phase CONSOLIDATION UNCLASSIFIED
Current IV / %ile 68.8% (35th %ile) N/A (N/A)
Put/Call OI Skew 0.14x (Call-Skewed) N/A
OBV Trend / Tech Phase ACCUMULATION · Markup NEUTRAL · Markdown
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Medical Devices Operator Medical Devices Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: SENS (5) vs VTAK (5)
Institutional Metric SENS VTAK Criterion Row Edge
Market Capitalization
Scale
$579.6M $548,639 Larger Scale SENS
Trailing P/E Ratio
Valuation
21.0x N/M Lower Multiple SENS
Forward P/E Ratio
Valuation
21.0x N/M Lower Multiple SENS
Revenue Growth (YoY)
Growth
+141.6% +380.7% Higher Growth VTAK
Operating Margin (TTM)
Profitability
-201.0% -388.1% Higher Margin SENS
Net Profit Margin
Profitability
-204.2% 0.0% Higher Margin VTAK
Return on Equity (ROE)
Capital Efficiency
-157.3% -111.3% Higher ROE VTAK
52-Week Range Position
Momentum
66% ($5–$14) 1% ($0–$3) Stronger Trend SENS
Beta / 30D Volatility
Risk Regime
1.98β · 101% Vol 0.19β · 76% Vol Lower Realized Risk VTAK
Unified Institutional Score
Composite Signal
38.9 / 100 (SELL) 58.1 / 100 (HOLD) Higher Composite VTAK
Trailing 12M Revenue (USD)
Operating Scale
$60M $1.9M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
58.7% 47.7% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 9.9x EV/Rev N/M PEG · 0.3x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$114M ($13M Net Debt (0.79x D/E)) -$10M EBITDA ($4.87 Book/Sh · -111.3% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon SENS +24.16 pp
SENS: -0.6% · VTAK: -24.76%
3M Horizon SENS +155.78 pp
SENS: +75.49% · VTAK: -80.29%
6M Horizon SENS +126.95 pp
SENS: +43.19% · VTAK: -83.76%
1Y Horizon SENS +152.5 pp
SENS: +59.87% · VTAK: -92.63%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period SENS Revenue VTAK Revenue SENS Op. Margin VTAK Op. Margin Margin Leader
FY2018 $0M $10M -4295.1% -498.0% VTAK
FY2019 $0M $10M -2653.6% -801.9% VTAK
FY2020 $0M $0M -5784.4% -13668.3% SENS
FY2021 $0M $0M -4102.0% -133027.3% SENS
FY2022 $20M $0M -418.7% -192578.6% SENS
FY2023 $20M $0M -337.7% -17674.0% SENS
FY2024 $20M $0M -333.0% -2676.9% SENS
FY2025 $40M $0M -193.8% -2581.6% SENS

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
SENS CONSOLIDATION
37d in phase · OBV ACCUMULATION
Current IV 68.8%
IV Percentile 35th %ile
Put/Call OI Skew 0.14x (Call-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow ACCUMULATION
Exact SENS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
VTAK UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact VTAK Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
SENS Moat Profile Cyclical / Execution-Driven Positioning
Medical Devices Operator
Competes within the Medical Devices value chain with $579.6M market capitalization and -201.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
VTAK Moat Profile Cyclical / Execution-Driven Positioning
Medical Devices Operator
Competes within the Medical Devices value chain with $548,639 market capitalization and -388.1% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ SENS vs VTAK Key Questions & Quantitative Answers

As of Nov 16, 2026, Senseonics Holdings, Inc. (SENS) is the stronger overall head-to-head candidate over Catheter Precision, Inc. (VTAK) in the Tradestie Institutional Equity Comparison Engine, winning 5–5 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). SENS carries a Unified Composite Score of 38.9/100 (SELL) at $10.90 (21.0x Forward P/E, -201.0% operating margin), whereas VTAK carries 58.1/100 (HOLD) at $0.15 (N/M Forward P/E, -388.1% operating margin). Composite vs. Pillar Nuance: While VTAK currently prints a higher short-term Unified Composite Score (58.1/100 HOLD vs. SENS 38.9/100 SELL), SENS captures the overall institutional head-to-head verdict (5–5 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (-201.0% vs. -388.1% operating margin) and revenue trajectory (+141.6% vs. +380.7% YoY). Technical & Structure Timing Caution: SENS trades in a Markup technical trend (CONSOLIDATION options phase, RSI 64.1); meanwhile VTAK is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 33.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

SENS leads the Growth & Scale pillar: SENS posts +141.6% YoY revenue growth and +0.0% YoY earnings growth on $60M TTM revenue (58.7% gross margin, -201.0% operating margin), compared with VTAK at +380.7% YoY revenue growth and +0.0% YoY earnings growth on $1.9M TTM revenue (47.7% gross margin, -388.1% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), SENS cumulative revenue shifted +100.0% while VTAK shifted +0.0%. In operating R&D and SG&A reinvestment, SENS deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for VTAK.

SENS screens cheaper on headline valuation multiples. SENS trades at 21.0x Forward P/E, 21.0x Trailing P/E, N/M PEG, and 9.9x EV/Revenue (unreported FCF margin), whereas VTAK trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.3x EV/Revenue (unreported EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against SENS (-157.3% ROE) versus VTAK (-111.3% ROE) capital efficiency.

In options market volatility and institutional positioning, SENS carries 68.8% implied volatility (35th %ile, Balanced (25th–60th %ile)), a 0.14x (Call-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a CONSOLIDATION options structure phase (1.98β · 101% Vol realized risk). By comparison, VTAK carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.19β · 76% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.